Subscribe to RSS
Subjective quality of life and treatment strategies in schizophrenia outpatient care
In quality management (QM), the patients’ perspective is an important outcome indicator. A Bavarian QM project – partially under the auspices of the German competence network for schizophrenia– questioned schizophrenic outpatients chosen at random about their quality of life with the Munich List of Quality of Life Dimensions (1) in order to make proposals for improving the quality of treatment.
The statements of 450 patients showed satisfactory validity and reliability. There were negative correlations between the quality of life and psychopathology (e. g. positive and negative symptom scale) or side effects. There was no difference in the global subjective quality of life between conventional and new antipsychotics. Wherever differences showed up in individual areas of life, the statements were more favorable for conventional antipsychotics or depot medication. The significance of these results is discussed in the light of the fact that the patient characteristics in the two subgroups diverge in areas which can likewise have an effect on the subjective evaluation.
1. Heinisch, M. et al. In: Bullinger, M. et al eds. Lebensqualitìt bei kardiovaskulìren Erkrankungen. Göttingen: Hogrefe; 1991. p. 73–90